To stop or continue aspirin before aortocoronary bypass operations— do we have enough evidence to adequately guide us?

Aspirin is a cornerstone in secondary prevention of myocardial infarction (MI) and reduces mortality and ischemic events after coronary artery bypass grafting (CABG) (1,2).